The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms

Appendiceal cancers (AC) are a rare and heterogeneous group of malignancies. Historically, appendiceal neoplasms have been grouped with colorectal cancers (CRC), and treatment strategies have been modeled after CRC management guidelines due to their structural similarities and anatomical proximity....

Full description

Bibliographic Details
Main Authors: Luisa Ladel, Wan Ying Tan, Thanushiya Jeyakanthan, Bethsebie Sailo, Anup Sharma, Nita Ahuja
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/15/1962
_version_ 1797586975575769088
author Luisa Ladel
Wan Ying Tan
Thanushiya Jeyakanthan
Bethsebie Sailo
Anup Sharma
Nita Ahuja
author_facet Luisa Ladel
Wan Ying Tan
Thanushiya Jeyakanthan
Bethsebie Sailo
Anup Sharma
Nita Ahuja
author_sort Luisa Ladel
collection DOAJ
description Appendiceal cancers (AC) are a rare and heterogeneous group of malignancies. Historically, appendiceal neoplasms have been grouped with colorectal cancers (CRC), and treatment strategies have been modeled after CRC management guidelines due to their structural similarities and anatomical proximity. However, the two have marked differences in biological behavior and treatment response, and evidence suggests significant discrepancies in their respective genetic profiles. In addition, while the WHO classification for appendiceal cancers is currently based on traditional histopathological criteria, studies have demonstrated that histomorphology does not correlate with survival or treatment response in AC. Due to their rarity, appendiceal cancers have not been studied as extensively as other gastrointestinal cancers. However, their incidence has been increasing steadily over the past decade, making it crucial to identify new and more effective strategies for detection and treatment. Recent efforts to map and understand the molecular landscape of appendiceal cancers have unearthed a wealth of information that has made it evident that appendiceal cancers possess a unique molecular profile, distinct from other gastrointestinal cancers. This review focuses on the epigenetic landscape of epithelial appendiceal cancers and aims to provide a comprehensive overview of the current state of knowledge of epigenetic changes across different appendiceal cancer subtypes, highlighting the challenges as well as the promise of employing epigenetics in the quest for the detection of biomarkers, therapeutic targets, surveillance markers, and predictors of treatment response and survival in epithelial appendiceal neoplasms.
first_indexed 2024-03-11T00:30:48Z
format Article
id doaj.art-d6a9fa65ef5c4ea89dd331000ef92a82
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T00:30:48Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-d6a9fa65ef5c4ea89dd331000ef92a822023-11-18T22:44:59ZengMDPI AGCells2073-44092023-07-011215196210.3390/cells12151962The Promise of Epigenetics Research in the Treatment of Appendiceal NeoplasmsLuisa Ladel0Wan Ying Tan1Thanushiya Jeyakanthan2Bethsebie Sailo3Anup Sharma4Nita Ahuja5Surgical Oncology Research Laboratories, Division of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT 06519, USASurgical Oncology Research Laboratories, Division of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT 06519, USASurgical Oncology Research Laboratories, Division of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT 06519, USASurgical Oncology Research Laboratories, Division of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT 06519, USASurgical Oncology Research Laboratories, Division of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT 06519, USASurgical Oncology Research Laboratories, Division of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT 06519, USAAppendiceal cancers (AC) are a rare and heterogeneous group of malignancies. Historically, appendiceal neoplasms have been grouped with colorectal cancers (CRC), and treatment strategies have been modeled after CRC management guidelines due to their structural similarities and anatomical proximity. However, the two have marked differences in biological behavior and treatment response, and evidence suggests significant discrepancies in their respective genetic profiles. In addition, while the WHO classification for appendiceal cancers is currently based on traditional histopathological criteria, studies have demonstrated that histomorphology does not correlate with survival or treatment response in AC. Due to their rarity, appendiceal cancers have not been studied as extensively as other gastrointestinal cancers. However, their incidence has been increasing steadily over the past decade, making it crucial to identify new and more effective strategies for detection and treatment. Recent efforts to map and understand the molecular landscape of appendiceal cancers have unearthed a wealth of information that has made it evident that appendiceal cancers possess a unique molecular profile, distinct from other gastrointestinal cancers. This review focuses on the epigenetic landscape of epithelial appendiceal cancers and aims to provide a comprehensive overview of the current state of knowledge of epigenetic changes across different appendiceal cancer subtypes, highlighting the challenges as well as the promise of employing epigenetics in the quest for the detection of biomarkers, therapeutic targets, surveillance markers, and predictors of treatment response and survival in epithelial appendiceal neoplasms.https://www.mdpi.com/2073-4409/12/15/1962appendiceal cancerepigeneticstranslational researchcancer biomarkersgastrointestinal cancerprecision oncology
spellingShingle Luisa Ladel
Wan Ying Tan
Thanushiya Jeyakanthan
Bethsebie Sailo
Anup Sharma
Nita Ahuja
The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms
Cells
appendiceal cancer
epigenetics
translational research
cancer biomarkers
gastrointestinal cancer
precision oncology
title The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms
title_full The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms
title_fullStr The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms
title_full_unstemmed The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms
title_short The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms
title_sort promise of epigenetics research in the treatment of appendiceal neoplasms
topic appendiceal cancer
epigenetics
translational research
cancer biomarkers
gastrointestinal cancer
precision oncology
url https://www.mdpi.com/2073-4409/12/15/1962
work_keys_str_mv AT luisaladel thepromiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT wanyingtan thepromiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT thanushiyajeyakanthan thepromiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT bethsebiesailo thepromiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT anupsharma thepromiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT nitaahuja thepromiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT luisaladel promiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT wanyingtan promiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT thanushiyajeyakanthan promiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT bethsebiesailo promiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT anupsharma promiseofepigeneticsresearchinthetreatmentofappendicealneoplasms
AT nitaahuja promiseofepigeneticsresearchinthetreatmentofappendicealneoplasms